{"doc_id": "si-2024-0528-reg-1", "parent_doc_id": "si-2024-0528", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 528 of 2024", "title": "“Principal Regulations” means the Infectious Diseases Regulations 1981 (S.I.", "year": 2024, "heading": "1. (1) These Regulations may be cited as the Infectious Diseases", "text_raw": "1. (1) These Regulations may be cited as the Infectious Diseases \n\n(Amendment) (No. 2) Regulations 2024. \n\n(2) The collective citation “The Infectious Diseases Regulations 1981 to \n\n2024” includes these Regulations.", "text_norm": "1 (1) regulation may cited infectious disease (amendment) (no 2) regulation 2024 (2) collective citation infectious disease regulation 1981 2024 includes regulation", "start_char": 452, "end_char": 670, "source_path": "downloads\\2024\\2024_0528.pdf", "extraction_method": "pdfminer", "checksum": "sha256:33b830bd283eb4ff0f89b7cba574bd6db748d7f279335dad78f1b3dbef90f99e", "cross_refs": []}
{"doc_id": "si-2024-0528-reg-2", "parent_doc_id": "si-2024-0528", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 528 of 2024", "title": "“Principal Regulations” means the Infectious Diseases Regulations 1981 (S.I.", "year": 2024, "heading": "In these Regulations—", "text_raw": "2. \n\nIn these Regulations— \n\n“Principal Regulations” means the Infectious Diseases Regulations 1981 (S.I. \nNo. 390 of 1981); \n\n“Regulations of 2024” means the Infectious Diseases (Amendment) Regulations \nof 2024 (S.I. No. 119 of 2024).", "text_norm": "2 regulations-- principal regulation mean infectious disease regulation 1981 (s.i no 390 1981) regulation 2024 mean infectious disease (amendment) regulation 2024 (s.i no 119 2024)", "start_char": 670, "end_char": 908, "source_path": "downloads\\2024\\2024_0528.pdf", "extraction_method": "pdfminer", "checksum": "sha256:33b830bd283eb4ff0f89b7cba574bd6db748d7f279335dad78f1b3dbef90f99e", "cross_refs": []}
{"doc_id": "si-2024-0528-reg-3", "parent_doc_id": "si-2024-0528", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 528 of 2024", "title": "“Principal Regulations” means the Infectious Diseases Regulations 1981 (S.I.", "year": 2024, "heading": "3. Regulation 14(1)(b) (as last amended by Regulation 4 of the Regulations", "text_raw": "3. Regulation 14(1)(b) (as last amended by Regulation 4 of the Regulations \n\nof 2024) of the Principal Regulations is amended by— \n\n(a) \n\n(b) \n\ndeleting “enterohaemorrhagic escherichia coli,”, and \n\ninserting “verotoxigenic escherichia coli infection,” before “viral \nhaemorrhagic fevers (Lassa, Marburg, Ebola, Crimean-Congo)”.", "text_norm": "3 regulation 14(1)(b) (as last amended regulation 4 regulation 2024) principal regulation amended by-- (a) (b) deleting enterohaemorrhagic escherichia coli inserting verotoxigenic escherichia coli infection viral haemorrhagic fever (lassa marburg ebola crimean-congo)", "start_char": 908, "end_char": 1239, "source_path": "downloads\\2024\\2024_0528.pdf", "extraction_method": "pdfminer", "checksum": "sha256:33b830bd283eb4ff0f89b7cba574bd6db748d7f279335dad78f1b3dbef90f99e", "cross_refs": []}
{"doc_id": "si-2024-0528-reg-4", "parent_doc_id": "si-2024-0528", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 528 of 2024", "title": "“Principal Regulations” means the Infectious Diseases Regulations 1981 (S.I.", "year": 2024, "heading": "4. Regulation 15(2)(a) (as amended by Regulation 5 of the Regulations of", "text_raw": "4. Regulation 15(2)(a) (as amended by Regulation 5 of the Regulations of \n\n2024) of the Principal Regulations is amended by— \n\n(a) \n\n(b) \n\ndeleting “enterohaemorrhagic escherichia coli,”, and \n\ninserting “verotoxigenic escherichia coli infection,” before “viral \nhaemorrhagic fevers (Lassa, Marburg, Ebola, Crimean-Congo)”.", "text_norm": "4 regulation 15(2)(a) (as amended regulation 5 regulation 2024) principal regulation amended by-- (a) (b) deleting enterohaemorrhagic escherichia coli inserting verotoxigenic escherichia coli infection viral haemorrhagic fever (lassa marburg ebola crimean-congo)", "start_char": 1239, "end_char": 1565, "source_path": "downloads\\2024\\2024_0528.pdf", "extraction_method": "pdfminer", "checksum": "sha256:33b830bd283eb4ff0f89b7cba574bd6db748d7f279335dad78f1b3dbef90f99e", "cross_refs": []}
{"doc_id": "si-2024-0528-reg-5", "parent_doc_id": "si-2024-0528", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 528 of 2024", "title": "“Principal Regulations” means the Infectious Diseases Regulations 1981 (S.I.", "year": 2024, "heading": "5. The Principal Regulations are amended by substituting for the Schedule", "text_raw": "5. The Principal Regulations are amended by substituting for the Schedule \n\n(inserted by Regulation 6 of the Regulations of 2024) the following: \n\nNotice of the making of this Statutory Instrument was published in \n\"Iris Oifigiúil\" of 11th October, 2024. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[528] 3 \n\n“Schedule \n\nDiseases specified to be infectious diseases and their respective causative \npathogens \n\nDisease \nAcute anterior poliomyelitis \n\nCausative Pathogen \nPolio virus \n\nAno-genital warts \n\nHuman papilloma virus \n\nAnthrax \n\nBacillus cereus food-borne \ninfection/intoxication \n\nBacterial meningitis (not otherwise \nspecified) \n\nBacillus anthracis \n\nBacillus cereus \n\nBotulism \n\nBrucellosis \n\nClostridium botulinum \n\nBrucella species \n\nCampylobacter infection \n\nCampylobacter species \n\nCarbapenemase producing \nenterobacteriaceae, infection or \ncolonisation \n\nEnterobacteriaceae \n\nChancroid \n\nHaemophilus ducreyi \n\nChickenpox - hospitalised cases \n\nVaricella-zoster virus \n\nChikungunya disease \n\nChikungunya virus \n\nChlamydia trachomatis infection (genital) Chlamydia trachomatis \n\nCholera \n\nVibrio cholerae \n\nClostridium difficile infection \n\nClostridium difficile \n\nClostridium perfringens (type A) food- \nborne disease \n\nClostridium perfringens \n\nCovid-19 \n\nSARS-CoV-2 \n\nCreutzfeldt Jakob disease \n\nvariant Creutzfeldt Jakob disease \n\nCryptosporidiosis \n\nCryptosporidium parvum, hominis \n\nCytomegalovirus infection (congenital) Cytomegalovirus \nDengue Fever \n\nDengue Virus \n\nDiphtheria \n\nCorynebacterium diphtheriae or \nulcerans (toxin producing) \n\n \n \n \n \n \n \n \n \n\f4 [528] \n\nEchinococcosis \n\nEchinococcus species \n\nEnterococcal bacteraemia \n\nEnterococcus species (blood) \n\nEscherichia coli infection (invasive) \n\nEscherichia coli (blood, CSF) \n\nGiardiasis \n\nGonorrhoea \n\nGiardia lamblia \n\nNeisseria gonorrhoeae \n\nGranuloma inguinale \n\nKlebsiella granulomatis \n\nHaemophilus influenzae disease \n(invasive) \n\nHaemophilus influenzae (blood, CSF \nor other normally sterile site) \n\nHepatitis A (acute) infection \n\nHepatitis A virus \n\nHepatitis B (acute and chronic) infection Hepatitis B virus \n\nHepatitis C infection \n\nHepatitis E Infection \n\nHepatitis C virus \n\nHepatitis E virus \n\nHerpes simplex (genital) \n\nHerpes simplex virus \n\nHerpes simplex (neonatal) \n\nHerpes simplex virus \n\nHuman immunodeficiency virus \ninfection \nHuman papilloma virus (HPV) infection \n(residual unlinked clinical specimens) \n\nHuman immunodeficiency virus \n\nHuman Papillomavirus (high risk \ngenotypes) \n\nInfluenza \n\nInfluenza A and B virus \n\nKlebsiella pneumoniae infection \n(invasive) \n\nKlebsiella pneumoniae (blood or \nCSF) \n\nLegionellosis \n\nLeprosy \n\nLeptospirosis \n\nListeriosis \n\nLegionella species \n\nMycobacterium leprae \n\nLeptospira species \n\nListeria monocytogenes \n\nLyme disease (neuroborreliosis) \n\nBorrelia burgdorferi \n\nLymphogranuloma venereum \n\nChlamydia trachomatis \n\nMalaria \n\nPlasmodium falciparum, vivax, \nknowlesi, ovale, malariae \n\nmcr-positive Enterobacteriaceae \n\nEnterobacteriaceae \n\ninfection or colonisation \nMeasles \n\nMeasles virus \n\nMeningococcal disease \n\nNeisseria meningitidis \n\n \n \n \n \n\f[528] 5 \n\nMpox \n\nMumps \n\nMonkeypox virus of the \nOrthopoxvirus genus \nMumps virus \n\nNon-specific urethritis \n\nNovel or Rare Antimicrobial-resistant \nOrganism (NRAO) \n\nNoroviral infection \n\nNorovirus \n\nParatyphoid \n\nPertussis \n\nPlague \n\nSalmonella Paratyphi \n\nBordetella pertussis \n\nYersinia pestis \n\nPseudomonas aeruginosa infection \n(invasive) \n\nPseudomonas aeruginosa (blood or \nCSF) \n\nQ Fever \n\nRabies \n\nCoxiella burnetii \n\nRabies virus \n\nRespiratory syncytial virus infection \n\nRespiratory syncytial virus \n\nRotavirus infection \n\nRubella \n\nSalmonellosis \n\nSevere Acute Respiratory Syndrome \n(SARS) \n\nRotavirus \n\nRubella virus \n\nSalmonella spp other than S. Typhi \nand S. Paratyphi \n\nSARS-associated coronavirus \n\nShigellosis \n\nSmallpox \n\nShigella species \n\nVariola virus \n\nStaphylococcal food poisoning \n\nEnterotoxigenic Staphylococcus \naureus \n\nStaphylococcus aureus bacteraemia \n\nStaphylococcus aureus (blood) \n\nStreptococcus group A infection \n(invasive) \n\nStreptococcus pyogenes (blood, CSF \nor other normally sterile site) \n\nStreptococcus group B infection \n(invasive) \n\nStreptococcus agalactiae (blood, CSF, \nor other normally sterile site) \n\nStreptococcus pneumoniae infection \n(invasive) \n\nStreptococcus pneumoniae (blood, \nCSF or other normally sterile site) \n\nSyphilis \n\nTetanus \n\nTreponema pallidum \n\nClostridium tetani \n\nToxoplasmosis \n\nToxoplasma gondii \n\n \n \n \n \n \n\f6 [528] \n\nTrichinosis \n\nTrichomoniasis \n\nTuberculosis \n\nTularemia \n\nTyphoid \n\nTyphus \n\nTrichinella species \n\nTrichomonas vaginalis \n\nMycobacterium tuberculosis complex \n\nFrancisella tularensis \n\nSalmonella Typhi \n\nRickettsia prowazekii \n\nVerotoxigenic Escherichia coli infection Verotoxin producing Escherichia coli \n\nViral encephalitis \n\nViral haemorrhagic fevers \n\nViral meningitis \n\nWest Nile fever \n\nYellow fever \n\nYersiniosis \n\nWest Nile virus \n\nYellow fever virus \n\nYersinia enterocolitica, Yersinia \npseudotuberculosis \n\nZika virus infection \n\nZika virus”. \n\nGIVEN under my Official Seal, \n\n8 October, 2024. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[528] 7", "text_norm": "5 principal regulation amended substituting schedule (inserted regulation 6 regulation 2024) following notice making statutory instrument published iris oifigiuil 11th october 2024 528 3 schedule disease specified infectious disease respective causative pathogen disease acute anterior poliomyelitis causative pathogen polio virus ano-genital wart human papilloma virus anthrax bacillus cereus food-borne infection intoxication bacterial meningitis (not otherwise specified) bacillus anthracis bacillus cereus botulism brucellosis clostridium botulinum brucella specie campylobacter infection campylobacter specie carbapenemase producing enterobacteriaceae infection colonisation enterobacteriaceae chancroid haemophilus ducreyi chickenpox - hospitalised case varicella-zoster virus chikungunya disease chikungunya virus chlamydia trachomatis infection (genital) chlamydia trachomatis cholera vibrio cholerae clostridium difficile infection clostridium difficile clostridium perfringens (type a) food- borne disease clostridium perfringens covid-19 sars-cov-2 creutzfeldt jakob disease variant creutzfeldt jakob disease cryptosporidiosis cryptosporidium parvum hominis cytomegalovirus infection (congenital) cytomegalovirus dengue fever dengue virus diphtheria corynebacterium diphtheriae ulcerans (toxin producing) 4 528 echinococcosis echinococcus specie enterococcal bacteraemia enterococcus specie (blood) escherichia coli infection (invasive) escherichia coli (blood csf) giardiasis gonorrhoea giardia lamblia neisseria gonorrhoeae granuloma inguinale klebsiella granulomatis haemophilus influenzae disease (invasive) haemophilus influenzae (blood csf normally sterile site) hepatitis (acute) infection hepatitis virus hepatitis b (acute chronic) infection hepatitis b virus hepatitis c infection hepatitis e infection hepatitis c virus hepatitis e virus herpes simplex (genital) herpes simplex virus herpes simplex (neonatal) herpes simplex virus human immunodeficiency virus infection human papilloma virus (hpv) infection (residual unlinked clinical specimens) human immunodeficiency virus human papillomavirus (high risk genotypes) influenza influenza b virus klebsiella pneumoniae infection (invasive) klebsiella pneumoniae (blood csf) legionellosis leprosy leptospirosis listeriosis legionella specie mycobacterium leprae leptospira specie listeria monocytogenes lyme disease (neuroborreliosis) borrelia burgdorferi lymphogranuloma venereum chlamydia trachomatis malaria plasmodium falciparum vivax knowlesi ovale malariae mcr-positive enterobacteriaceae enterobacteriaceae infection colonisation measles measles virus meningococcal disease neisseria meningitidis 528 5 mpox mumps monkeypox virus orthopoxvirus genus mumps virus non-specific urethritis novel rare antimicrobial-resistant organism (nrao) noroviral infection norovirus paratyphoid pertussis plague salmonella paratyphi bordetella pertussis yersinia pestis pseudomonas aeruginosa infection (invasive) pseudomonas aeruginosa (blood csf) q fever rabies coxiella burnetii rabies virus respiratory syncytial virus infection respiratory syncytial virus rotavirus infection rubella salmonellosis severe acute respiratory syndrome (sars) rotavirus rubella virus salmonella spp s typhi s paratyphi sars-associated coronavirus shigellosis smallpox shigella specie variola virus staphylococcal food poisoning enterotoxigenic staphylococcus aureus staphylococcus aureus bacteraemia staphylococcus aureus (blood) streptococcus group infection (invasive) streptococcus pyogenes (blood csf normally sterile site) streptococcus group b infection (invasive) streptococcus agalactiae (blood csf normally sterile site) streptococcus pneumoniae infection (invasive) streptococcus pneumoniae (blood csf normally sterile site) syphilis tetanus treponema pallidum clostridium tetani toxoplasmosis toxoplasma gondii 6 528 trichinosis trichomoniasis tuberculosis tularemia typhoid typhus trichinella specie trichomonas vaginalis mycobacterium tuberculosis complex francisella tularensis salmonella typhi rickettsia prowazekii verotoxigenic escherichia coli infection verotoxin producing escherichia coli viral encephalitis viral haemorrhagic fever viral meningitis west nile fever yellow fever yersiniosis west nile virus yellow fever virus yersinia enterocolitica yersinia pseudotuberculosis zika virus infection zika virus  given official seal 8 october 2024 stephen donnelly minister health 528 7", "start_char": 1565, "end_char": 6764, "source_path": "downloads\\2024\\2024_0528.pdf", "extraction_method": "pdfminer", "checksum": "sha256:33b830bd283eb4ff0f89b7cba574bd6db748d7f279335dad78f1b3dbef90f99e", "cross_refs": []}
{"doc_id": "si-2024-0528-explanatory-note", "parent_doc_id": "si-2024-0528", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 528 of 2024", "title": "“Principal Regulations” means the Infectious Diseases Regulations 1981 (S.I.", "year": 2024, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Schedule to the Infectious Diseases Regulations \n1981 (S.I. No. 390 of 1981), as inserted by Regulation 6 of Infectious Diseases \n(Amendment) Regulations of 2024 (S.I. No. 119 of 2024), to include ‘Human \npapilloma virus (HPV) infection (residual unlinked clinical specimens)’ amongst \nthe list of diseases designated as an ‘infectious disease’ for the purposes of the \nHealth Act 1947. \n\nIn addition, these Regulations amend the Principal Regulations to provide for \nthe preliminary notification (i.e. immediate notification by telephone) of \n‘Verotoxigenic Escherichia coli infection’ and remove ‘enterohaemorrhagic \nescherichia coli’. \n\n \n \n \n \n \n \n \n\f8 [528] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-548) 30. 10/24. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend schedule infectious disease regulation 1981 (s.i no 390 1981) inserted regulation 6 infectious disease (amendment) regulation 2024 (s.i no 119 2024) include human papilloma virus (hpv) infection (residual unlinked clinical specimens) amongst list disease designated infectious disease purpose health act 1947 addition regulation amend principal regulation provide preliminary notification (i.e immediate notification telephone) verotoxigenic escherichia coli infection remove enterohaemorrhagic escherichia coli  8 528 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 3.00 (dh-548) 30 10 24 propylon", "start_char": 6764, "end_char": 8056, "source_path": "downloads\\2024\\2024_0528.pdf", "extraction_method": "pdfminer", "checksum": "sha256:33b830bd283eb4ff0f89b7cba574bd6db748d7f279335dad78f1b3dbef90f99e", "cross_refs": []}
